Last Price
10.91
Today's Change
+0.058 (0.53%)
Day's Change
10.83 - 11.55
Trading Volume
49,881
Overview
Market Cap
115 Million
Shares Outstanding
10 Million
Avg Volume
26,542
Avg Price (50 Days)
9.01
Avg Price (200 Days)
6.84
PE Ratio
-1.98
EPS
-5.51
Earnings Announcement
11-Nov-2024
Previous Close
10.86
Open
11.00
Day's Range
10.835 - 11.55
Year Range
2.69 - 12.89
Trading Volume
49,987
Price Change Highlight
1 Day Change
0.53%
5 Day Change
18.67%
1 Month Change
33.96%
3 Month Change
15.29%
6 Month Change
98.50%
Ytd Change
233.87%
1 Year Change
227.86%
3 Year Change
-82.06%
5 Year Change
-93.32%
10 Year Change
-99.61%
Max Change
-99.82%
News and Blogs
No result.
Company Profile
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
Benitec Biopharma Inc., a development-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal muscular dystrophy; and BB-103 for the treatment of chronic hepatitis B virus infection. The company was incorporated in 1995 and is headquartered in Hayward, California.
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Featured Posts
12
Apps
Top Articles
1
CEO Morning Brief
Uniqlo Owner Targets Higher Sales From Strong Western Market
2
CEO Morning Brief
3
4
CEO Morning Brief
5
CEO Morning Brief
#
Stock
Score
9
First Trust Exchange-Traded Fund Viii - Cboe Vest U S Equity Buffer and Premium Income Etf
625
Daily Stocks
Stock
Last
Change
Volume
Stock
Last
Change
Volume
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
